<HashMap><database>ENA</database><file_versions><headers><Content-Type>application/xml</Content-Type></headers><body><files><Fastqsanger.gz>ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR122/028/SRR12265428/SRR12265428_1.fastq.gz</Fastqsanger.gz><Fastqsanger.gz>ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR122/024/SRR12265424/SRR12265424_1.fastq.gz</Fastqsanger.gz><Fastqsanger.gz>ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR122/027/SRR12265427/SRR12265427_1.fastq.gz</Fastqsanger.gz><Fastqsanger.gz>ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR122/023/SRR12265423/SRR12265423_2.fastq.gz</Fastqsanger.gz><Fastqsanger.gz>ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR122/026/SRR12265426/SRR12265426_2.fastq.gz</Fastqsanger.gz><Fastqsanger.gz>ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR122/025/SRR12265425/SRR12265425_1.fastq.gz</Fastqsanger.gz><Fastqsanger.gz>ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR122/028/SRR12265428/SRR12265428_2.fastq.gz</Fastqsanger.gz><Fastqsanger.gz>ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR122/025/SRR12265425/SRR12265425_2.fastq.gz</Fastqsanger.gz><Fastqsanger.gz>ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR122/023/SRR12265423/SRR12265423_1.fastq.gz</Fastqsanger.gz><Fastqsanger.gz>ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR122/024/SRR12265424/SRR12265424_2.fastq.gz</Fastqsanger.gz><Fastqsanger.gz>ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR122/026/SRR12265426/SRR12265426_1.fastq.gz</Fastqsanger.gz><Fastqsanger.gz>ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR122/027/SRR12265427/SRR12265427_2.fastq.gz</Fastqsanger.gz></files><type>primary</type></body><statusCode>OK</statusCode><statusCodeValue>200</statusCodeValue></file_versions><scores/><additional><omics_type>Genomics</omics_type><center_name>Texas A&amp;M</center_name><full_dataset_link>https://www.ebi.ac.uk/ena/browser/view/PRJNA647225</full_dataset_link><long_description>Transcriptomic analysis of ebselen on Clostridioides difficile as part of study to re-evaluate ebselen anti-C. difficile properties</long_description><tag>xref:EuropePMC:PMC8557875</tag><repository>ENA</repository><description_synonyms>antibiotic, antimicrobial, RP 60931, DR 3305, Activity, antibiotique, antimicrobials, Clostridium difficile (Hall and O'Toole 1935) Prevot 1938 (Approved Lists 1980), cysteine metabolism., Antibiotika, 2-phenylbenzoisoselenazol-3(2H)-one, SPI-1005, antimicrobial agents, DR3305, 2-benzoisoselenazol-3(2H)-one, 2-phenyl-1, PZ 51, DR-3305, microbicides, SPI 1005, Clostridium difficile, PZ-51, microbicide, SPI1005, General activity, Peptoclostridium difficile, antibiotics, Antibiotikum</description_synonyms></additional><is_claimable>false</is_claimable><name></name><description>Ebselen Exhibits Antimicrobial Activity Against Clostridioides difficile By Disrupting Cysteine Metabolism</description><dates><last_updated>2023-05-17</last_updated><first_public>2021-01-02</first_public></dates><accession>PRJNA647225</accession><cross_references/></HashMap>